Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
Alpine Immune Sciences
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALPN-101
|
| gptkbp:intendedUse |
autoimmune diseases
|
| gptkbp:macromoleculeType |
gptkb:protein
|
| gptkbp:mechanismOfAction |
dual CD28/ICOS antagonist
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:CD28
gptkb:ICOS |
| gptkbp:bfsParent |
gptkb:Alpine_Immune_Sciences,_Inc.
|
| gptkbp:bfsLayer |
7
|